Articles by James Calloway
GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision
GSK's Arexvy RSV vaccine application has been accepted for review by China's drug regulator, with a potential approval decision expected in 2027. The stock edged higher as JPMorgan raised its price target and the company's dividend ex-date approaches.
Barclays Initiates £1 Billion Buyback Amid Profit Growth and U.S. Fee Concerns
Barclays has commenced a £1 billion share repurchase program following a 12% rise in annual pretax profit, while investors monitor regulatory risks to its U.S. card operations.
AppLovin Shares Gain Ahead of Q4 Report Amid Analyst Target Adjustments
AppLovin's stock advanced 2.7% in extended trading Tuesday, continuing a rebound as investors await quarterly results. UBS trimmed its price target but maintained a Buy rating, citing strength in the company's ad technology.
Meta Shares Dip Amid Regulatory Pressure in Germany and India
Meta Platforms stock declined roughly 1% in after-hours trading following a German court ruling ordering a €30 million payment to Deutsche Telekom and India's new three-hour content removal mandate.
Robinhood Braces for Post-Earnings Volatility as Options Signal Major Move
Options markets are pricing in a potential double-digit swing for Robinhood shares following its Q4 earnings report, with analysts upgrading the stock amid a crypto-driven selloff.
Reddit Shares Surge 5% as Analysts Recalibrate Following Strong Q4
Reddit stock climbed over 5% in afternoon trading, defying a flat broader market, as Wall Street analysts adjusted price targets following last week's robust earnings report and a new $1 billion share buyback authorization.
DoorDash Shares Edge Lower Ahead of Q4 Earnings Amid Economic Uncertainty
DoorDash stock declined slightly as investors await the company's upcoming earnings report, with attention on consumer demand and margins against a backdrop of flat retail sales and pending economic data.
Home Depot Shares Gain Ahead of Earnings as Investors Eye Housing Demand
Home Depot stock advanced 2.6% to $390.84, outpacing a flat S&P 500, as investors rotated into consumer stocks following soft retail sales data. The focus now shifts to the company's quarterly report on February 24.
Workday Shares Extend Decline Following Unexpected CEO Transition
Workday stock fell further as co-founder Aneel Bhusri reassumed the CEO role, replacing Carl Eschenbach. Investors await quarterly results for margin outlook and details on $135 million in restructuring costs.
Amphenol Shares Stabilize Near $145 Following Earnings-Driven Rally
Amphenol shares held steady Tuesday after a strong Monday bounce driven by better-than-expected earnings. Investors are now focused on the upcoming dividend payment and a planned leadership transition in 2026.
Datadog Surges 15% on Strong Q4 Results Amid Lingering AI Sector Concerns
Datadog shares soared nearly 15% after reporting Q4 revenue of $953.2M and adjusted EPS of $0.59, both exceeding expectations. The company forecast full-year revenue up to $4.10B.
ZoomInfo Shares Tumble on Stagnant 2026 Revenue Forecast
ZoomInfo's stock fell sharply after projecting flat revenue for 2026, despite a strong Q4 earnings beat and a new $1 billion share repurchase program.